Debt Market Update – Q3 2026

A Growing Market, A Narrower Gate

If it feels like venture lenders are becoming less ad-“venture”-ous, you may be onto something.

Venture growth credit – large facilities extended to late-stage and pre-IPO companies – continue to account for an outsized share of venture debt dollar volume. These facilities are concentrated primarily in AI infrastructure, AI-adjacent technology, and aerospace and defense.

Through the first three quarters of 2026, venture growth credit accounted for approximately 80% of total venture debt dollar volume ($65.0 billion of $81.2 billion), despite representing just 48% of deal count (240 of 498 transactions).

The median deal size jumped to $14.9 million – more than three times the $4.25 million median in 2025. This reflects a shift in stage mix toward larger, later-stage facilities, rather than a uniform credit expansion.

This illustrates a “K-shaped” dynamic playing out in venture debt: record annual totals are on track to exceed $81.7 billion in 2026, surpassing 2025’s full-year total of $69.7 billion with one quarter remaining. But this growth is likely driven by a handful of high-conviction growth credit positions rather than broad-based lending activity.

Q3 2026 venture debt totaled $36.7 billion across 345 deals, down in headline dollar volume from Q2’s $45 billion. However, Q2’s headline volume was dominated by SpaceX’s $20 billion senior notes facility. Stripping that single transaction, underlying Q2 volume was approximately $24–$25 billion.

On an adjusted basis, Q3 deal value rose approximately 34% quarter-over-quarter, while deal count more than doubled from 154 to 345 transactions – the highest quarterly deal count of the year by a wide margin.

The broader U.S. venture equity market mirrors this pattern. Year-to-date investment reached approximately $515.8 billion, a record, driven largely by a small number of massive AI infrastructure rounds. Q3 equity activity normalized to approximately $98.4 billion across 3,640 deals, a more moderate pace consistent with historical norms.

Healthcare debt pulled back sharply in Q3, while technology – adjusting for the SpaceX outlier in Q2 – showed meaningful improvement in both volume and breadth.

Across both sectors, the dominant theme remains in selectivity concentrated at the top: a small number of high-quality late-stage and growth-stage credits attract significant capital on favorable terms, while the broader market remains cautious.

To gain more insights into the venture debt market in Q3 2026, download the full report and read Lenteris Advisors Quarterly Debt Market Update.